<p>ING Groep NV 在最近向证券交易委员会提交的文件中表示，在第四季度将其在 Molina Healthcare, Inc (NYSE:MOH - 免费报告) 的持股比例提高了 575.7%。该机构投资者在此期间购买了额外的 40,336 股后，拥有该公司 47,343 股股票。ING Groep NV 在最近一个季度末持有的 Molina Healthcare 约占 0.09%，价值 8,216,000 美元。</p>
<p>获取 <strong>Molina Healthcare</strong> 警报：</p>
<ul>
<li>3 个下跌行业值得买入，1 个应当远离</li>
</ul>
<p>其他一些对冲基金和机构投资者也对 MOH 的持仓进行了调整。Torren Management LLC 在第四季度以 26,000 美元的估值收购了 Molina Healthcare 的新股份。Miller Global Investments LLC 在第四季度以 27,000 美元的估值购买了 Molina Healthcare 的新股份。MUFG Securities EMEA plc 在第二季度以 48,000 美元的估值购买了 Molina Healthcare 的新股份。Cromwell Holdings LLC 在第四季度将其在 Molina Healthcare 的持仓提高了 211.9%。Cromwell Holdings LLC 现在拥有该公司 184 股股票，价值 32,000 美元，此前在此期间又收购了 125 股。最后，Rakuten Securities Inc. 在第四季度将其在 Molina Healthcare 的持仓提高了 5,020.0%。Rakuten Securities Inc. 现在拥有该公司 256 股股票，价值 44,000 美元，此前在上个季度又收购了 251 股。机构投资者和对冲基金持有该公司 98.50% 的股票。</p>
<h2>Molina Healthcare 股价上涨 0.2%</h2>
<p>周一，MOH 股票开盘价为 191.16 美元。Molina Healthcare, Inc 的 12 个月低点为 121.06 美元，12 个月高点为 311.52 美元。该公司的 50 日移动平均线为 168.40 美元，200 日移动平均线为 162.57 美元。公司的流动比率为 1.63，速动比率为 1.63，债务与股本比率为 0.97。该股票的市值为 99.6 亿美元，市盈率为 56.56，贝塔值为 0.80。</p>
<ul>
<li>Centene 股票为何下跌 40% — 现在是否值得买入</li>
</ul>
<p>Molina Healthcare (NYSE:MOH - 获取免费报告) 最近于 4 月 22 日发布了其财报。该公司报告本季度每股收益为 2.35 美元，超出市场共识预期的 1.57 美元，超出幅度为 0.78 美元。该公司本季度的收入为 108 亿美元，而市场共识预期为 109.1 亿美元。Molina Healthcare 的股本回报率为 8.76%，净利润率为 0.42%。与去年同期相比，该公司的季度收入下降了 3.1%。去年同期，该公司每股收益为 6.08 美元。Molina Healthcare 将其 2026 财年的指导目标设定为 5.000- 每股收益。根据分析师的平均预期，Molina Healthcare, Inc 本财年将发布 5.23 的每股收益。</p>
<h2>内部人士下注</h2>
<p>在其他 Molina Healthcare 的新闻中，首席会计官 Maurice Hebert 于 5 月 14 日星期四出售了 600 股 Molina Healthcare 股票。该股票以平均价格 191.55 美元出售，总交易额为 114,930.00 美元。出售后，首席会计官持有该公司 12,815 股股票，价值 2,454,713.25 美元。此次交易使其持仓减少了 4.47%。该交易已在向 SEC 提交的文件中披露，相关文件可通过此超链接获取。此外，内部人士 Jeff D. Barlow 于 5 月 11 日星期一出售了 17,811 股该公司的股票。该股票以平均价格 186.12 美元出售，总交易额为 3,314,983.32 美元。出售后，内部人士直接持有该公司 67,175 股股票，价值 12,502,611 美元。此次交易使其持仓减少了 20.96%。有关此次出售的更多细节可在官方 SEC 披露中找到。公司内部人士持有该公司 1.44% 的股票。</p>
<h2>华尔街分析师预测增长</h2>
<ul>
<li>3 家在市场动荡中表现良好的健康保险股票</li>
</ul>
<p>一些研究公司最近对 MOH 进行了评论。Cantor Fitzgerald 在 5 月 11 日的研究报告中将 Molina Healthcare 的目标价格从 144.00 美元上调至 209.00 美元，并给予该公司 “中性” 评级。Wall Street Zen 在 5 月 2 日的报告中将 Molina Healthcare 的评级从 “卖出” 上调至 “持有”。Mizuho 在 3 月 12 日的研究报告中将 Molina Healthcare 的目标价格从 220.00 美元下调至 180.00 美元，并对该公司给予 “跑赢大盘” 评级。Barclays 在 5 月 26 日的研究报告中将 Molina Healthcare 的目标价格从 161.00 美元上调至 199.00 美元，并给予该股票 “减持” 评级。最后，Zacks Research 在 4 月 20 日的研究报告中将 Molina Healthcare 的评级从 “强烈卖出” 上调至 “持有”。三位分析师对该股票给予买入评级，十一位给予持有评级，两位给予卖出评级。根据 MarketBeat.com 的数据，该公司的共识评级为 “持有”，共识目标价格为 179.93 美元。</p>
<p><strong>查看我们最新的 Molina Healthcare 股票报告</strong></p>
<h2>关于 Molina Healthcare</h2>
<p>（免费报告）</p>
<p>Molina Healthcare, Inc 是一家专注于政府资助健康保险计划的管理医疗公司。该公司提供医疗补助管理护理计划、医疗保险优势和处方药计划，以及根据《平价医疗法案》提供的个人市场计划。通过综合护理模式，Molina 强调预防和初级护理服务、护理协调和疾病管理，以改善其成员的健康结果。</p>
<p>该公司的根源可以追溯到 1980 年代初期，当时 Dr.</p>
<h2>推荐故事</h2>
<ul>
<li>五只我们更看好的股票，胜过 Molina Healthcare</li>
<li>这 3 只保险股票创下新 52 周高点：还有时间买入吗？</li>
<li>3 只股价低于 20 美元的股票，值得在更广泛的市场反弹前买入</li>
<li>Petco 面临激烈竞争，但势头正在增强</li>
<li>锁定效应是真实存在的——这 3 家房屋建筑商正在押注于此</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU1PSA?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU1PSA"/></p>
<p><em>此即时新闻提醒是由叙事科学技术和来自 MarketBeat 的金融数据生成的，旨在为读者提供最快的报道和公正的覆盖。请将有关此故事的任何问题或评论发送至 contact@marketbeat.com.</em></p>
<h2>你现在应该投资 1,000 美元在 Molina Healthcare 吗？</h2>
<p>在考虑 Molina Healthcare 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而 Molina Healthcare 并不在名单上。</p>
<p>虽然 Molina Healthcare 目前在分析师中被评为持有评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

Molina医疗

荷兰国际

4755

<p>ING Groep NV 在第四季度将其在 Molina Healthcare 的股份增加了 575.7%，持有 47,343 股，价值 820 万美元。其他机构投资者如乐天证券和克朗威尔控股也显著增加了他们的持仓。同时，内部人士莫里斯·赫伯特和杰夫·D·巴洛出售了股份。分析师调整了评级和价格目标，Cantor Fitzgerald 将其目标价上调至 209 美元</p>

<p>ING Groep NV grew its stake in Molina Healthcare, Inc (NYSE:MOH - Free Report) by 575.7% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 47,343 shares of the company's stock after purchasing an additional 40,336 shares during the period. ING Groep NV owned about 0.09% of Molina Healthcare worth $8,216,000 at the end of the most recent quarter.</p>
<div class="lb-trans"><p>ING Groep NV 在最近向证券交易委员会提交的文件中表示，在第四季度将其在 Molina Healthcare, Inc (NYSE:MOH - 免费报告) 的持股比例提高了 575.7%。该机构投资者在此期间购买了额外的 40,336 股后，拥有该公司 47,343 股股票。ING Groep NV 在最近一个季度末持有的 Molina Healthcare 约占 0.09%，价值 8,216,000 美元。</p>
</div><p>Get <strong>Molina Healthcare</strong> alerts:</p>
<div class="lb-trans"><p>获取 <strong>Molina Healthcare</strong> 警报：</p>
</div><ul>
<li>3 Sectors to Buy While They're Down and 1 to Walk Away From</li>
</ul>
<div class="lb-trans"><ul>
<li>3 个下跌行业值得买入，1 个应当远离</li>
</ul>
</div><p>A number of other hedge funds and other institutional investors have also made changes to their positions in MOH. Torren Management LLC acquired a new position in shares of Molina Healthcare in the 4th quarter valued at $26,000. Miller Global Investments LLC purchased a new position in Molina Healthcare in the fourth quarter valued at $27,000. MUFG Securities EMEA plc purchased a new position in Molina Healthcare in the second quarter valued at $48,000. Cromwell Holdings LLC raised its position in shares of Molina Healthcare by 211.9% in the fourth quarter. Cromwell Holdings LLC now owns 184 shares of the company's stock worth $32,000 after acquiring an additional 125 shares during the period. Finally, Rakuten Securities Inc. boosted its stake in shares of Molina Healthcare by 5,020.0% during the 4th quarter. Rakuten Securities Inc. now owns 256 shares of the company's stock worth $44,000 after acquiring an additional 251 shares in the last quarter. Institutional investors and hedge funds own 98.50% of the company's stock.</p>
<div class="lb-trans"><p>其他一些对冲基金和机构投资者也对 MOH 的持仓进行了调整。Torren Management LLC 在第四季度以 26,000 美元的估值收购了 Molina Healthcare 的新股份。Miller Global Investments LLC 在第四季度以 27,000 美元的估值购买了 Molina Healthcare 的新股份。MUFG Securities EMEA plc 在第二季度以 48,000 美元的估值购买了 Molina Healthcare 的新股份。Cromwell Holdings LLC 在第四季度将其在 Molina Healthcare 的持仓提高了 211.9%。Cromwell Holdings LLC 现在拥有该公司 184 股股票，价值 32,000 美元，此前在此期间又收购了 125 股。最后，Rakuten Securities Inc. 在第四季度将其在 Molina Healthcare 的持仓提高了 5,020.0%。Rakuten Securities Inc. 现在拥有该公司 256 股股票，价值 44,000 美元，此前在上个季度又收购了 251 股。机构投资者和对冲基金持有该公司 98.50% 的股票。</p>
</div><h2>Molina Healthcare Trading Up 0.2%</h2>
<div class="lb-trans"><h2>Molina Healthcare 股价上涨 0.2%</h2>
</div><p>MOH stock opened at $191.16 on Monday. Molina Healthcare, Inc has a 12-month low of $121.06 and a 12-month high of $311.52. The business's 50-day moving average is $168.40 and its 200 day moving average is $162.57. The company has a current ratio of 1.63, a quick ratio of 1.63 and a debt-to-equity ratio of 0.97. The stock has a market cap of $9.96 billion, a price-to-earnings ratio of 56.56 and a beta of 0.80.</p>
<div class="lb-trans"><p>周一，MOH 股票开盘价为 191.16 美元。Molina Healthcare, Inc 的 12 个月低点为 121.06 美元，12 个月高点为 311.52 美元。该公司的 50 日移动平均线为 168.40 美元，200 日移动平均线为 162.57 美元。公司的流动比率为 1.63，速动比率为 1.63，债务与股本比率为 0.97。该股票的市值为 99.6 亿美元，市盈率为 56.56，贝塔值为 0.80。</p>
</div><ul>
<li>Why Centene Stock Dropped 40% — And Whether It's a Buy Now</li>
</ul>
<div class="lb-trans"><ul>
<li>Centene 股票为何下跌 40% — 现在是否值得买入</li>
</ul>
</div><p>Molina Healthcare (NYSE:MOH - Get Free Report) last released its earnings results on Wednesday, April 22nd. The company reported $2.35 earnings per share for the quarter, beating the consensus estimate of $1.57 by $0.78. The business had revenue of $10.80 billion for the quarter, compared to the consensus estimate of $10.91 billion. Molina Healthcare had a return on equity of 8.76% and a net margin of 0.42%.The business's quarterly revenue was down 3.1% compared to the same quarter last year. During the same quarter last year, the business posted $6.08 earnings per share. Molina Healthcare has set its FY 2026 guidance at 5.000- EPS. On average, sell-side analysts anticipate that Molina Healthcare, Inc will post 5.23 EPS for the current fiscal year.</p>
<div class="lb-trans"><p>Molina Healthcare (NYSE:MOH - 获取免费报告) 最近于 4 月 22 日发布了其财报。该公司报告本季度每股收益为 2.35 美元，超出市场共识预期的 1.57 美元，超出幅度为 0.78 美元。该公司本季度的收入为 108 亿美元，而市场共识预期为 109.1 亿美元。Molina Healthcare 的股本回报率为 8.76%，净利润率为 0.42%。与去年同期相比，该公司的季度收入下降了 3.1%。去年同期，该公司每股收益为 6.08 美元。Molina Healthcare 将其 2026 财年的指导目标设定为 5.000- 每股收益。根据分析师的平均预期，Molina Healthcare, Inc 本财年将发布 5.23 的每股收益。</p>
</div><h2>Insiders Place Their Bets</h2>
<div class="lb-trans"><h2>内部人士下注</h2>
</div><p>In other Molina Healthcare news, CAO Maurice Hebert sold 600 shares of Molina Healthcare stock in a transaction on Thursday, May 14th. The shares were sold at an average price of $191.55, for a total transaction of $114,930.00. Following the sale, the chief accounting officer owned 12,815 shares of the company's stock, valued at $2,454,713.25. The trade was a 4.47% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, insider Jeff D. Barlow sold 17,811 shares of the company's stock in a transaction on Monday, May 11th. The stock was sold at an average price of $186.12, for a total transaction of $3,314,983.32. Following the sale, the insider directly owned 67,175 shares of the company's stock, valued at $12,502,611. The trade was a 20.96% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Company insiders own 1.44% of the company's stock.</p>
<div class="lb-trans"><p>在其他 Molina Healthcare 的新闻中，首席会计官 Maurice Hebert 于 5 月 14 日星期四出售了 600 股 Molina Healthcare 股票。该股票以平均价格 191.55 美元出售，总交易额为 114,930.00 美元。出售后，首席会计官持有该公司 12,815 股股票，价值 2,454,713.25 美元。此次交易使其持仓减少了 4.47%。该交易已在向 SEC 提交的文件中披露，相关文件可通过此超链接获取。此外，内部人士 Jeff D. Barlow 于 5 月 11 日星期一出售了 17,811 股该公司的股票。该股票以平均价格 186.12 美元出售，总交易额为 3,314,983.32 美元。出售后，内部人士直接持有该公司 67,175 股股票，价值 12,502,611 美元。此次交易使其持仓减少了 20.96%。有关此次出售的更多细节可在官方 SEC 披露中找到。公司内部人士持有该公司 1.44% 的股票。</p>
</div><h2>Wall Street Analysts Forecast Growth</h2>
<div class="lb-trans"><h2>华尔街分析师预测增长</h2>
</div><ul>
<li>3 Health Insurance Stocks Holding Green in Market Turmoil</li>
</ul>
<div class="lb-trans"><ul>
<li>3 家在市场动荡中表现良好的健康保险股票</li>
</ul>
</div><p>A number of research firms have recently commented on MOH. Cantor Fitzgerald raised their target price on Molina Healthcare from $144.00 to $209.00 and gave the company a &#34;neutral&#34; rating in a research report on Monday, May 11th. Wall Street Zen raised Molina Healthcare from a &#34;sell&#34; rating to a &#34;hold&#34; rating in a report on Saturday, May 2nd. Mizuho cut their price objective on Molina Healthcare from $220.00 to $180.00 and set an &#34;outperform&#34; rating for the company in a research report on Thursday, March 12th. Barclays upped their target price on Molina Healthcare from $161.00 to $199.00 and gave the stock an &#34;underweight&#34; rating in a research note on Tuesday, May 26th. Finally, Zacks Research raised shares of Molina Healthcare from a &#34;strong sell&#34; rating to a &#34;hold&#34; rating in a research note on Monday, April 20th. Three analysts have rated the stock with a Buy rating, eleven have given a Hold rating and two have given a Sell rating to the company's stock. According to data from MarketBeat.com, the company has a consensus rating of &#34;Hold&#34; and a consensus target price of $179.93.</p>
<div class="lb-trans"><p>一些研究公司最近对 MOH 进行了评论。Cantor Fitzgerald 在 5 月 11 日的研究报告中将 Molina Healthcare 的目标价格从 144.00 美元上调至 209.00 美元，并给予该公司 “中性” 评级。Wall Street Zen 在 5 月 2 日的报告中将 Molina Healthcare 的评级从 “卖出” 上调至 “持有”。Mizuho 在 3 月 12 日的研究报告中将 Molina Healthcare 的目标价格从 220.00 美元下调至 180.00 美元，并对该公司给予 “跑赢大盘” 评级。Barclays 在 5 月 26 日的研究报告中将 Molina Healthcare 的目标价格从 161.00 美元上调至 199.00 美元，并给予该股票 “减持” 评级。最后，Zacks Research 在 4 月 20 日的研究报告中将 Molina Healthcare 的评级从 “强烈卖出” 上调至 “持有”。三位分析师对该股票给予买入评级，十一位给予持有评级，两位给予卖出评级。根据 MarketBeat.com 的数据，该公司的共识评级为 “持有”，共识目标价格为 179.93 美元。</p>
</div><p><strong>View Our Latest Stock Report on Molina Healthcare</strong></p>
<div class="lb-trans"><p><strong>查看我们最新的 Molina Healthcare 股票报告</strong></p>
</div><h2>About Molina Healthcare</h2>
<div class="lb-trans"><h2>关于 Molina Healthcare</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>（免费报告）</p>
</div><p>Molina Healthcare, Inc is a managed care company specializing in government-sponsored health insurance programs. The company offers Medicaid managed care plans, Medicare Advantage and prescription drug plans, and individual Marketplace plans under the Affordable Care Act. Through an integrated care model, Molina emphasizes preventive and primary care services, care coordination, and disease management to improve health outcomes for its members.</p>
<div class="lb-trans"><p>Molina Healthcare, Inc 是一家专注于政府资助健康保险计划的管理医疗公司。该公司提供医疗补助管理护理计划、医疗保险优势和处方药计划，以及根据《平价医疗法案》提供的个人市场计划。通过综合护理模式，Molina 强调预防和初级护理服务、护理协调和疾病管理，以改善其成员的健康结果。</p>
</div><p>The company traces its roots to the early 1980s, when Dr.</p>
<div class="lb-trans"><p>该公司的根源可以追溯到 1980 年代初期，当时 Dr.</p>
</div><h2>Recommended Stories</h2>
<div class="lb-trans"><h2>推荐故事</h2>
</div><ul>
<li>Five stocks we like better than Molina Healthcare</li>
<li>These 3 Insurance Stocks Made New 52-Week Highs: Still Time to Buy?</li>
<li>3 Stocks Under $20 to Buy Before a Broader Market Rally</li>
<li>Petco Faces Tough Competition, But Momentum Is Building</li>
<li>The Lock-In Effect Is Real—These 3 Homebuilders Are Betting on It</li>
</ul>
<div class="lb-trans"><ul>
<li>五只我们更看好的股票，胜过 Molina Healthcare</li>
<li>这 3 只保险股票创下新 52 周高点：还有时间买入吗？</li>
<li>3 只股价低于 20 美元的股票，值得在更广泛的市场反弹前买入</li>
<li>Petco 面临激烈竞争，但势头正在增强</li>
<li>锁定效应是真实存在的——这 3 家房屋建筑商正在押注于此</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU1PSA" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NYSE&amp;Symbol=MOH"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒是由叙事科学技术和来自 MarketBeat 的金融数据生成的，旨在为读者提供最快的报道和公正的覆盖。请将有关此故事的任何问题或评论发送至 contact@marketbeat.com.</em></p>
</div><h2>Should You Invest $1,000 in Molina Healthcare Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在 Molina Healthcare 吗？</h2>
</div><p>Before you consider Molina Healthcare, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑 Molina Healthcare 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Molina Healthcare wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而 Molina Healthcare 并不在名单上。</p>
</div><p>While Molina Healthcare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 Molina Healthcare 目前在分析师中被评为持有评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

荷兰国际集团增持了 Molina 医疗公司的股份 $MOH